Primary Record
lonidamine
- In stock
- 4,078 g
- Purity
- 98.1 %
- CAS
- 50264-69-2
Compound Identifiers & Properties
- CAS
- 50264-69-2
- PubChem CID
- 39562
- SMILES
- C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O
- Canonical SMILES
- O=C(O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12
Names & Synonyms
- lonidamine
- Doridamina
- Diclondazolic acid
- DICA
- 50264-69-2
- Lonidamina
- Lonidaminum
- Lonidamin
- 1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid
- null
- Lonidamine?
- Doridamina (TN)
- Dichlondazolic acid
- Lonidamine (INN)
- Lonidaminum [INN-Latin]
- Lonidamina [INN-Spanish]
- Lonidamine [BAN:INN]
- C15H10Cl2N2O2
- Lonidamine [INN:BAN]
- AF 1890
- Lonidamine (Standard)
- Tocris-1646
- LONIDAMINE [MI]
- DTXSID5020782
- LONIDAMINE [INN]
- RefChem:154047
- CCRIS 3516
- Lopac-L-4900
- U78804BIDR
- UNII-U78804BIDR
- MFCD00866285
- D09SIR
- DTXCID90782
- AC1L21YG
- LONIDAMINE [MART.]
- MLS000028822
- SCHEMBL7134
- WDRYRZXSPDWGEB-UHFFFAOYSA-N
- AF-1890
- LONIDAMINE [WHO-DD]
- Lopac0_000718
- CHEBI:50138
- cid_39562
- NSC-741419
- NSC-758419
- EINECS 256-510-0
- 1-(2,4-Dichlorbenzyl)-indazole-3-carboxylic acid
- KN-228
- orb1310804
- ZINC1632
- 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid
- 1-[(2,4-dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid
- AF-1890;Diclondazolic Acid;DICA
- CHEMBL1257030
- SCHEMBL29350056
- SCHEMBL29351122
- BDBM59775
- CTK1H1686
- GTPL12601
- HY-B0486R
- KS-00000XLL
- BRN 0894483
- L01XX07
- TH-070
- 1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid
- GLXC-06932
- HMS2234H24
- HMS3262O17
- HMS3268K09
- HMS3369I01
- HMS3412P05
- HMS3651F09
- HMS3676P05
- HMS3874D03
- HMS5081J11
- HMS6018L14
- Pharmakon1600-01503225
- ACT02617
- BCP06555
- CID39562
- HY-B0486
- Tox21_110181
- Tox21_202306
- Tox21_500718
- AF1890
- C15-H10-Cl2-N2-O2
- CID:39562
- EBC-03786
- HB0993
- NCGC00015609-03
- NP3131
- NSC741419
- NSC758419
- s2610
- SMR000058467
- AKOS012842739
- Tox21_110181_1
- AC-5626
- CCG-204803
- CS-2602
- DB06266
- FL32739
- LP00718
- LS-7474
- NSC 741419
- NSC 758419
- SDCCGSBI-0050696.P003
- NCGC00015609-01
- NCGC00015609-02
- NCGC00015609-04
- NCGC00015609-05
- NCGC00015609-06
- NCGC00015609-07
- NCGC00015609-08
- NCGC00015609-09
- NCGC00015609-16
- NCGC00025244-01
- NCGC00025244-02
- NCGC00025244-03
- NCGC00259855-01
- NCGC00261403-01
- AJ-08062
- AN-10756
- AS-11653
- BC213253
- BR-73119
- J10.376D
- SC-75962
- SID:53789939
- L 4900
- SBI-0050696.P002
- AB0010495
- AB2000699
- CAS-50264-69-2
- ST2414921
- TR-017970
- 1H-Indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)-
- 4CH-014644
- AM20060642
- B1964
- EU-0100718
- FT-0650359
- L0283
- NS00032024
- SW219810-1
- 5-25-04-00250 (Beilstein Handbook Reference)
- Lonidamine, mitochondrial hexokinase inhibitor
- 1H-Indazole-3-carboxylic acid, 1-[(2,4-dichlorophenyl)methyl]-
- D07257
- EN300-345010
- J90044
- S-4929
- AB00597141_08
- AB00597141_10
- 264L692
- A929099
- C016371
- SR-01000075961
- 1H-Indazole-3-carboxylic acid, 1-(2,4-dichlorobenzyl)-
- I01-0912
- Q3836670
- SR-01000075961-1
- SR-01000075961-3
- SR-01000075961-6
- 1-(2,4-dichlorophenyl)-1h-indazol-3-carboxylic acid
- BRD-K78513633-001-03-3
- BRD-K78513633-001-06-6
- BRD-K78513633-001-13-2
- BRD-K78513633-001-14-0
- BRD-K78513633-001-15-7
- 1-(2,4-dichlorobenzyl)-1-H-indazole-3-carboxylic acid
- 1H-Indazole-3-carboxylicacid, 1-[(2,4-dichlorophenyl)methyl]-
- Z1137008901
- 1-((2,4-dichlorophenyl)methyl)indazole-3-carboxylic acid
- 1-[(2,4-dichlorophenyl)methyl]-3-indazolecarboxylic acid
- 1-((2,4-Dichlorophenyl)methyl)-1H-indazole-3-carboxylic acid
- 1-[(2,4-DICHLOROPHENYL)METHYL]-1H-INDAZOLE-3-CARBO
- Lonidamine, 99%, mitochondrial hexokinase inhibitor - 1G 1g
- 1-[(2,6-DICHLOROPHENYL)METHYL]INDAZOLE-3-CARBOXYLIC ACID
- 1H-Indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)-(9CI)
- 256-510-0
- 50264-73-8